ADHD Medication Management

How We Prescribe & Monitor ADHD Medications 

 At Aspire ADHD, ADHD medications are prescribed only after a comprehensive clinical evaluation and when medication is determined to be medically appropriate. Our prescribing decisions are individualized based on each patient's age, symptoms, level of impairment, medical and psychiatric history, coexisting conditions, current medications, previous treatment response, potential side effects, treatment goals, and overall risk factors. 

Stimulant medications are generally considered first-line pharmacologic treatments for ADHD and, on average, produce greater reductions in core ADHD symptoms than non-stimulant medications. However, stimulants are not appropriate for every patient. Certain cardiovascular conditions, active substance use disorders, a history of medication misuse or diversion, psychotic disorders, bipolar disorder, severe anxiety, tic disorders, and other medical or psychiatric conditions may require additional evaluation, stabilization, closer monitoring, or consideration of alternative treatments.

Non-stimulant medications may be considered when stimulants are ineffective, poorly tolerated, contraindicated, or when the potential risks of stimulant treatment outweigh the expected benefits. The decision to prescribe a stimulant or non-stimulant medication is made on an individual basis after careful consideration of the patient's clinical history, treatment goals, and the potential risks and benefits of each treatment option.

For preschool-aged children with ADHD, behavioral interventions and parent training are generally recommended as the initial treatment approach. Medication may be considered when symptoms remain moderate to severe, cause significant functional impairment, and do not adequately improve with appropriate behavioral interventions.

Because most stimulant medications are Schedule II prescription medications, patient safety and responsible prescribing are essential parts of our treatment approach.

Before initiating stimulant treatment, we review each patient's:

• Medical history 
• Psychiatric history 
• Current medications 
• Cardiovascular risk factors 
• Substance use history 
• Risk of medication misuse or diversion 

The Prescription Drug Monitoring Program (PDMP) is reviewed when required and appropriate.

Additional evaluation or testing may be recommended based on individual risk factors and may include:

• Electrocardiogram (ECG) 
• Laboratory testing 
• Urine drug screening 
• Review of previous medical records 
• Consultation with another treating clinician 
• Medical or cardiac clearance before stimulant treatment is initiated or continued 

.

Patients prescribed stimulant medications participate in regular follow-up appointments so treatment effectiveness, medication adherence, and potential adverse effects can be monitored over time.

Follow-up care may include monitoring of:

• Blood pressure 
• Heart rate 
• Weight 
• Appetite 
• Sleep 
• Mood 
• Psychiatric symptoms 
• Overall functioning 

Stimulant medications are generally started at an appropriate dose and adjusted gradually based on clinical response and tolerability. Our goal is not simply to improve attention, but to achieve meaningful improvements in academic, occupational, social, and daily functioning while minimizing medication-related risks and side effects.

Aspire ADHD maintains controlled substance prescribing policies designed to promote patient safety, responsible medication use, and continuity of care.

Depending on the clinical situation, patients receiving stimulant medications may be required to:

• Sign a controlled substance treatment agreement 
• Complete urine drug screening when clinically indicated 
• Participate in pill counts when clinically indicated 
• Obtain controlled substance prescriptions from one designated prescriber and one designated pharmacy 

Early refills and replacement prescriptions for lost, stolen, damaged, or otherwise unavailable controlled medications are generally not provided. Medication changes and dose adjustments require an appropriate clinical assessment and may require a scheduled appointment. Patients are responsible for maintaining recommended follow-up appointments and requesting routine refills within the established timeframes.

Treatment plans are reviewed regularly and may be modified when a medication is ineffective, causes significant side effects, is not taken as prescribed, or when new medical, psychiatric, or safety concerns arise. When clinically appropriate, stimulant treatment may be adjusted, changed, temporarily held, or discontinued if continued prescribing is no longer considered medically appropriate.

Our goal is to provide individualized, evidence-based ADHD treatment that balances effective symptom management with careful monitoring, responsible prescribing, and long-term patient safety.